Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Histology and Histopathology|June 27, 2008
SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiationS Heebøll, M Borre, P D Ottosen, et al.
Biosensors & Bioelectronics|November 1, 2005
dc-Sheet resistance as sensitive monitoring tool of protein immobilization on thin metal filmsH Neff, T Beeby, A M N Lima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patientsL Schmidt, J Fredsøe, H Kristensen, et al.
British Journal of Cancer|January 17, 2013
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancerK D Sørensen, M O Abildgaard, C Haldrup, et al.
British Journal of Cancer|October 8, 2011
Low ANXA10 expression is associated with disease aggressiveness in bladder cancerP P Munksgaard, F Mansilla, A-S Brems Eskildsen, et al.
British Journal of Cancer|November 24, 2011
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerS B Villadsen, J B Bramsen, M S Ostenfeld, et al.
Pageof 5